Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT

SummaryUsing in vivo microcomputed tomography (micro-CT), we found in parathyroid hormone (PTH)-treated osteopenic rats linear increases in cortical and trabecular, due to increased trabecular thickness and number, bone mass. Bone was formed in cavities, leading to restoral of nearly cleaved trabeculae. For the first time, effects in PTH-treated rats were analyzed longitudinally.IntroductionOur aims were to over time (1) determine changes in trabecular thickness and number after PTH, (2) compare responses to PTH between the meta- and epiphysis, (3) determine effects of PTH on mineralization and mechanical properties, (4) determine locations of new bone formation due to PTH on a microlevel, and (5) determine the predictive value of bone structural properties for gain in bone mass after PTH.MethodsAdult rats were divided into ovariectomy (OVX; n = 8), SHAM-OVX (n = 8), and OVX and PTH treatment (n = 9). Between weeks 8 and 14, PTH rats received daily subcutaneous PTH injections (60 μg/kg/day). At weeks 0, 8, 10, 12, and 14, in vivo micro-CT scans were made of the proximal and diaphyseal tibia. After sacrifice, all tibiae were tested in three-point bending.ResultsPTH increased bone volume fraction linearly over time in meta- and epiphysis, accompanied by increased trabecular thickness in both and increased trabecular number only in the latter one. CT-estimated mineralization increased in trabecular and remained constant in cortical bone. Ultimate load and energy were increased and ultimate displacement and stiffness unaltered compared to SHAM rats. For those trabeculae analyzed, bone was formed initially on places where it was most beneficial for increasing their strength and later on to all surfaces.

[1]  T. Keaveny,et al.  Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  T. Wronski,et al.  Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. , 1999, Bone.

[3]  J. Compston.  Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. , 2007, Bone.

[4]  J. Thomsen,et al.  Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. , 1995, Bone.

[5]  L. Mosekilde,et al.  The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model. , 1995, Bone.

[6]  D. Burr.  Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size , 2005, Current osteoporosis reports.

[7]  R. Recker,et al.  Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength , 2006, Calcified Tissue International.

[8]  X. Guo,et al.  Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. , 2002, Bone.

[9]  J. Tuukkanen,et al.  Clodronate Prevents Osteopenia and Loss of Trabecular Connectivity in Estrogen‐Deficient Rats , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  C. Turner,et al.  Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment. , 2002, The Journal of pharmacology and experimental therapeutics.

[11]  R. Lindsay,et al.  Skeletal Effects of Parathyroid Hormone Infusion in Ovariectomized Rats With or Without Estrogen Repletion , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  D. Peehl,et al.  Calcitriol as a Chemopreventive and Therapeutic Agent in Prostate Cancer: Role of Anti‐Inflammatory Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  P. Kostenuik,et al.  Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats. , 2005, Bone.

[14]  Rik Huiskes,et al.  No effects of in vivo micro‐CT radiation on structural parameters and bone marrow cells in proximal tibia of wistar rats detected after eight weekly scans , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  J. Reeve,et al.  Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. , 1990, BMJ.

[16]  R. Lindsay,et al.  Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats. , 1997, Bone.

[17]  D. Burr,et al.  Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). , 2001, Bone.

[18]  R. Lindsay,et al.  Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. , 2003, Bone.

[19]  U. Iwaniec,et al.  A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats , 2007, Osteoporosis International.

[20]  F. Melsen,et al.  Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. , 1995, Bone.

[21]  J. Vahle,et al.  Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. , 2002, Endocrinology.

[22]  Y. Akiyama,et al.  Effects of vitamin K2 (menatetrenone) on calcium balance in ovariectomized rats. , 2002, Japanese journal of pharmacology.

[23]  Ara Nazarian,et al.  Specimen size and porosity can introduce error into microCT-based tissue mineral density measurements. , 2009, Bone.

[24]  L. Mosekilde,et al.  Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia. , 2000, Bone.

[25]  Y. Akiyama,et al.  Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats , 2007, Journal of Bone and Mineral Metabolism.

[26]  L. Mosekilde,et al.  No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model. , 1997, Bone.

[27]  H. Oxlund,et al.  Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. , 2004, Bone.

[28]  W. Jee,et al.  Overview: animal models of osteopenia and osteoporosis. , 2001, Journal of musculoskeletal & neuronal interactions.

[29]  A. Boyde,et al.  Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). , 2001, Bone.

[30]  R. Rizzoli,et al.  Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats. , 2002, Bone.

[31]  L. Palermo,et al.  Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis , 2007, Osteoporosis International.

[32]  P. Fratzl,et al.  Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  G. Andreas.  Quantitative Assessment of Bone Mass and Geometry by pQCT in Rats in vivo and Site Specificity of Changes at Different Skeletal Sites , 1997 .

[34]  J. Gasser.  Assessing bone quantity by pQCT. , 1995, Bone.

[35]  L. Mosekilde,et al.  A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model. , 1997, Bone.

[36]  T. Wronski,et al.  Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. , 1994, Bone.

[37]  M. Balooch,et al.  Both hPTH(1–34) and bFGF Increase Trabecular Bone Mass in Osteopenic Rats but They Have Different Effects on Trabecular Bone Architecture , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  C. Turner.  Biomechanics of Bone: Determinants of Skeletal Fragility and Bone Quality , 2002, Osteoporosis International.

[39]  R. Recker,et al.  Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. , 2007, Bone.

[40]  R. Recker,et al.  Treatment of Skeletally Mature Ovariectomized Rhesus Monkeys With PTH(1‐84) for 16 Months Increases Bone Formation and Density and Improves Trabecular Architecture and Biomechanical Properties at the Lumbar Spine , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  C. Turner,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Biosynthetic Human Parathyroid Hormone (1–34) Effects on Bone Quality in Aged Ovariectomized Rats , 2022 .

[42]  L. Stitt,et al.  A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. , 1997, The Journal of clinical endocrinology and metabolism.

[43]  J. Potts,et al.  Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients. , 1981, The Journal of clinical investigation.

[44]  M. Dalstra,et al.  Parathyroid hormone induces formation of new cancellous bone with substantial mechanical strength at a site where it had disappeared in old rats. , 2002, European journal of endocrinology.

[45]  T. Wronski,et al.  Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. , 1995, Bone.

[46]  R. Lindsay,et al.  Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  D. Drost,et al.  Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients. , 1991, Bone and mineral.

[48]  H. Weinans,et al.  Bone loss dynamics result in trabecular alignment in aging and ovariectomized rats , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  L. Mosekilde,et al.  The effect of long-term exercise on vertebral and femoral bone mass, dimensions, and strength--assessed in a rat model. , 1994, Bone.

[50]  Y. Washimi,et al.  Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats. , 2007, Bone.

[51]  Christian Graeff,et al.  Monitoring Teriparatide‐Associated Changes in Vertebral Microstructure by High‐Resolution CT In Vivo: Results From the EUROFORS Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  Lian-fang Huang,et al.  Effect of intermittent injection of recombinant human parathyroid hormone on bone histomorphometry of ovariectomized rats. , 2002, Acta pharmacologica Sinica.

[53]  R. Lindsay,et al.  Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity. , 2007, Bone.

[54]  J H Koolstra,et al.  Accuracy of microCT in the quantitative determination of the degree and distribution of mineralization in developing bone , 2006, Acta radiologica.

[55]  R. Recker,et al.  Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84. , 2008, Bone.

[56]  R. Boyce,et al.  Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  E L Ritman,et al.  Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Y. Tamura,et al.  Effects of h‐PTH on cancellous bone mass, connectivity, and bone strength in ovariectomized rats with and without sciatic‐neurectomy , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[59]  Y. Shimada,et al.  Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. , 2008, Bone.

[60]  R. Huiskes,et al.  A three-dimensional digital image correlation technique for strain measurements in microstructures. , 2004, Journal of biomechanics.